Full-Time
Veeva Systems
5,001-10,000 employees
Quality and regulatory software solutions provider
Compensation Overview
$65k - $140k/yr
Entry, Junior
Company Historically Provides H1B Sponsorship
Toronto, ON, Canada
Work in the nearest Veeva office four days/week.
Upload your resume to see how it matches 17 keywords from the job description.
PDF, DOC, DOCX, up to 4 MB
- Work in the nearest Veeva office four days/week
- Bachelor’s in Mathematics or Computer Science/Applications or a similar field
- Experience coding in Java AND/OR mobile languages
- Understanding of Software QA methodologies, tools, and approaches (black box and/or automated testing) in a software company with short-release cycles
- Graduate or relevant work experience, including software development and/or software test automation
- Curiosity and ability to quickly learn new technologies
- Strong verbal and written communication skills
- Create testing-related documentation, including test plans, test cases/scripts, and bug reports assessing quality and associated risk
- Automate and work closely with the automation group to automate features for better regression coverage
- Triage and/or assist with triaging of automation results
- Develop deep expertise in the product
- Conduct QA tests and verify outcomes within schedules/timelines
- Work with software engineers, product managers, and other QA testers in an Agile team environment
- Experience using Cypress
- Experience with SQL
- Knowledge of Java, Python, or other object-oriented programming language
- Knowledge of Atlassian products like Jira, Greenhopper, and Clover is an advantage
- Knowledge of modern best practices for software development
- Knowledge of Mobile Testing and Automation –Appium, XCUI, Espresso, KIF
- Knowledge of Mobile Apps Development (Android/iOS)
Veeva Systems offers software solutions for quality, regulatory, and advertising claims management, focusing on consumer products and chemical companies. Their cloud-based platform provides end-to-end visibility and traceability throughout the product journey, ensuring compliance with regulations and accelerating time-to-market. Unlike competitors, Veeva has expanded from the Life Sciences sector to address similar challenges in the Chemical and Consumer Goods markets. The company's goal is to modernize the product journey for clients while maintaining a subscription-based model for steady revenue.
Company Size
5,001-10,000
Company Stage
IPO
Headquarters
Pleasanton, California
Founded
2007
Simplify's Take
What believers are saying
- Veeva's SiteVault CTMS improves research site efficiency with seamless sponsor integration.
- Indero's success with Veeva RTSM highlights efficiency in clinical trial operations.
- Veeva's global reach includes over 950 customers in 165 countries.
What critics are saying
- EVERSANA ORCHESTRATE MLR poses a competitive threat to Veeva's MLR solutions.
- Tina Hunt's retirement may impact Veeva's leadership and strategic direction.
- Challenges in data integration may affect Veeva SiteVault CTMS adoption.
What makes Veeva Systems unique
- Veeva Systems specializes in cloud-based software for the life sciences industry.
- Veeva's subscription model ensures continuous updates and improvements for clients.
- Veeva offers end-to-end visibility and traceability in product journeys.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Parental leave
PTO
Free food
Health, dental, & vision insurance
Gym membership reimbursement
Growth & Insights and Company News
6 month growth
↑ 0%1 year growth
↑ 1%2 year growth
↑ 0%Platform built in collaboration with Amazon Web Services, Modus Create to produce unmatched accuracy, efficiencies and compliance for life science companiesCHICAGO – 10 April, 2025 - EVERSANA, a leading provider of commercial services to the life sciences industry, today announced the next milestone in its journey to transform and innovate commercialization with the launch of EVERSANA ORCHESTRATE MLR, an AI-powered, industry-integrated platform that revolutionizes the Medical, Legal, and Regulatory (MLR) process.EVERSANA ORCHESTRATE MLR automates 90 percent of common tasks in the complex review process through a single platform that’s easy to implement and complies with all regulatory requirements.The solution was built on Amazon Bedrock, which offers a choice of high-performing foundation models. EVERSANA worked with consulting firm Modus Create , EVERSANA’s Medical Affairs and Regulatory Affairs experts, and Veeva for seamless integration with Veeva PromoMats.“EVERSANA ORCHESTRATE MLR is a game-changer for the life science industry,” said Jim Lang, CEO. “Through the power of AI and our collaborations with leading technology providers and in-house MLR experts, we’ve set a new standard for efficiency, compliance, and quality that is much needed in today’s industry.”Shifting the Industry MLR Process from Manual to AutomatedMost organizations have a manual MLR review process, requiring teams to comb through hundreds of marketing materials and cross-reference them with the most accurate regulatory claims information available. EVERSANA ORCHESTRATE MLR automatically identifies, extracts and manages claims in minutes with the power of AI.Additionally, annotation and cross-referencing for creative-type documents against claims data can now be completed in just a few clicks. Users will see all claims identified in the document and what needs to be updated and can make these updates in real-time, resulting in 90 percent faster content updates and an overall reduction in content reviews by as much as 50 percent.By harnessing the power of Amazon Bedrock, EVERSANA will empower life sciences companies with the AI tools they need to mitigate a significant pain point for the healthcare industry— administrative burden. EVERSANA ORCHESTRATE MLR is just one example of how EVERSANA is using industry-leading AI solutions to solve some of healthcare’s most complex problems.“Generative AI is transforming the life sciences industry by accelerating R&D, improving efficiency in manufacturing, and streamlining the path to commercialization," said Dan Sheeran, general manager, Healthcare and Life Sciences, AWS
Cloud CTMS software to improve research site efficiency and integrate seamlessly with sponsorsPLEASANTON, Calif., April 1, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva SiteVault CTMS, a clinical trial management system for research sites that is integrated with SiteVault eISF and SiteVault eConsent to allow sites to comprehensively manage clinical trials within one main system. Integration with sponsors using Veeva's Clinical Platform gives sites seamless bidirectional data flow to sponsors to reduce manual processes and increase efficiency."We need to work efficiently to help more families enroll their children in studies and get lifesaving treatment," said Theresa Oswald, director of research operations and conduct at Ann & Robert H. Lurie Children's Hospital of Chicago. "In our experience, we have found that systems like Veeva SiteVault with a CTMS provide a streamlined user experience. This can help drive speed for the benefit of our patients.""We are excited to bring Veeva SiteVault CTMS to the industry," said Nick Frenzer, general manager, site solutions at Veeva. "High-quality cloud software and seamless sponsor integration will help sites be more efficient
Specialized CRO standardizes on Veeva RTSM to drive operational efficiency and faster study timelinesBARCELONA, Spain, March 19, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Indero, formerly Innovaderm Research, successfully launched its 40th RTSM study on Veeva RTSM. By standardizing with Veeva RTSM, Indero has strengthened its clinical trial operations, harnessing advanced RTSM capabilities and expert support to drive efficiency, enhance process consistency, and streamline execution."As we continue to optimize our clinical trial operations, Veeva RTSM has driven more efficient processes and closer collaboration to ensure seamless execution," said Eric Hardy, senior director, biometrics at Indero. "Because of this added speed and effectiveness, we can help bring therapies to market faster, allowing our sponsors, sites, and patients to benefit sooner."The launch of Indero's 40th RTSM study highlights the continued collaboration between the two organizations. Since first adopting Veeva RTSM, Indero has worked closely with Veeva to continuously refine and implement standardized processes that drive long-term success for its clinical trials."With its enterprise standard RTSM approach, Indero is achieving greater long-term efficiency and reliability in their studies," said Steve Simmerman, general manager, Veeva RTSM. "Partnering with Indero to standardize clinical processes will further accelerate study timelines, demonstrating a streamlined approach that can advance the industry."Additional InformationTo learn more about Veeva's enterprise standard RTSM, visit www.veeva.com/rtsm.About Veeva SystemsVeeva is the global leader in cloud software for the life sciences industry. Committed to innovation, product excellence, and customer success, Veeva serves more than 1,000 customers, ranging from the world's largest biopharmaceutical companies to emerging biotechs
Since first adopting Veeva RTSM, Indero has worked closely with Veeva to continuously refine and implement standardized processes that drive long-term success for its clinical trials.
Through its integrated solution with Veeva, Pulse Health helped its client collect essential details at a recent in-person industry gathering - contact info, email addresses, specialties, institution details and event notes.